These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1397060)

  • 1. Stereoisomerism and muscarinic receptor agonists: synthesis and effects of the stereoisomers of 3-[5-(3-amino-1,2,4-oxadiazol)yl]-1- azabicyclo[2.2.1]heptane.
    Pombo-Villar E; Wiederhold KH; Mengod G; Palacios JM; Supavilai P; Boddeke HW
    Eur J Pharmacol; 1992 Aug; 226(4):317-25. PubMed ID: 1397060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro biological profile of all four isomers of the potent muscarinic agonist 3-(3-methyl-1,2,4-oxadiazol-5-yl)-1-azabicyclo[2.2.1]heptane.
    Showell GA; Baker R; Davis J; Hargreaves R; Freedman SB; Hoogsteen K; Patel S; Snow RJ
    J Med Chem; 1992 Mar; 35(5):911-6. PubMed ID: 1548680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel series of non-quaternary oxadiazoles acting as full agonists at muscarinic receptors.
    Freedman SB; Harley EA; Patel S; Newberry NR; Gilbert MJ; McKnight AT; Tang JK; Maguire JJ; Mudunkotuwa NT; Baker R
    Br J Pharmacol; 1990 Nov; 101(3):575-80. PubMed ID: 2076477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J; Lembøl HL; Meier E; Pedersen H
    Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological properties of cloned muscarinic receptors expressed in A9 L cells; comparison with in vitro models.
    Boddeke HW; Buttini M
    Eur J Pharmacol; 1991 Sep; 202(2):151-7. PubMed ID: 1802743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-689,660, a novel cholinomimetic with functional selectivity for M1 and M3 muscarinic receptors.
    Hargreaves RJ; McKnight AT; Scholey K; Newberry NR; Street LJ; Hutson PH; Semark JE; Harley EA; Patel S; Freedman SB
    Br J Pharmacol; 1992 Oct; 107(2):494-501. PubMed ID: 1422595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 2-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8-azabicyclo [3.2.1]octanes and 2 alpha-(3-substituted-1,2,4-oxadiazol-5-yl)-8-methyl-8- azabicyclo[3.2.1]oct-2-enes as potential muscarinic agonists.
    Triggle DJ; Kwon YW; Abraham P; Rahman MA; Carroll FI
    Pharm Res; 1992 Nov; 9(11):1474-9. PubMed ID: 1475236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and neurochemical evaluation of 5-(3-alkyl-1,2,4- oxadiazol-5-yl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
    Dunbar PG; Durant GJ; Fang Z; Abuh YF; el-Assadi AA; Ngur DO; Periyasamy S; Hoss WP; Messer WS
    J Med Chem; 1993 Apr; 36(7):842-7. PubMed ID: 8464038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo.
    Freedman SB; Dawson GR; Iversen LL; Baker R; Hargreaves RJ
    Life Sci; 1993; 52(5-6):489-95. PubMed ID: 8441329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of muscarinic agonists in rat superior cervical ganglion and hippocampal slices.
    Boddeke HW
    Eur J Pharmacol; 1991 Aug; 201(2-3):191-7. PubMed ID: 1724649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
    Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
    Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of (1-azabicyclo[3.3.0]octanyl)methyl-substituted aromatic heterocycles and their muscarinic activity.
    Suzuki T; Uesaka H; Hamajima H; Ikami T
    Chem Pharm Bull (Tokyo); 1999 Jun; 47(6):876-9. PubMed ID: 10399839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacological study of the responses induced by muscarinic agonists on the isolated superior cervical ganglion of the guinea-pig.
    Roberts KE; Newberry NR
    Eur J Pharmacol; 1990 Sep; 186(2-3):257-65. PubMed ID: 2289527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodide.
    Giannella M; Piergentili A; Pigini M; Quaglia W; Rafaiani G; Tayebati SK
    Chem Pharm Bull (Tokyo); 1994 Jun; 42(6):1286-90. PubMed ID: 8069977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-687,306: a functionally selective and potent muscarinic M1 receptor agonist.
    Freedman SB; Patel S; Harley EA; Iversen LL; Baker R; Showell GA; Saunders J; McKnight A; Newberry N; Scholey K
    Eur J Pharmacol; 1992 Apr; 215(1):135-6. PubMed ID: 1516645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hexahydrodifenidol does not distinguish among M1 receptors in rat cerebral cortex, hippocampus and superior cervical ganglion.
    Freedman SB; Field JL; Gilbert MJ; Newberry NR
    Eur J Pharmacol; 1989 Aug; 167(3):411-4. PubMed ID: 2806379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes.
    Lambrecht G; Feifel R; Wagner-Röder M; Strohmann C; Zilch H; Tacke R; Waelbroeck M; Christophe J; Boddeke H; Mutschler E
    Eur J Pharmacol; 1989 Sep; 168(1):71-80. PubMed ID: 2583233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of the novel cholinomimetic L-689,660 at cloned and native brain muscarinic receptors.
    Aagaard P; McKinney M
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1478-83. PubMed ID: 8263809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors.
    Street LJ; Baker R; Book T; Kneen CO; MacLeod AM; Merchant KJ; Showell GA; Saunders J; Herbert RH; Freedman SB
    J Med Chem; 1990 Oct; 33(10):2690-7. PubMed ID: 2213823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological characterization of enantiomerically pure muscarinic agonists: difluoromuscarines.
    Angeli P; Cantalamessa F; Cavagna R; Conti P; De Amici M; De Micheli C; Gamba A; Marucci G
    J Med Chem; 1997 Mar; 40(7):1099-103. PubMed ID: 9089331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.